| Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP X Dong, CA Mattingly, MT Tseng, MJ Cho, Y Liu, VR Adams, RJ Mumper Cancer research 69 (9), 3918-3926, 2009 | 335 | 2009 |
| Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors VR Adams, M Leggas Clinical therapeutics 29 (7), 1338-1353, 2007 | 232 | 2007 |
| DELAYED GRAFT FUNCTION AFTER RENAL TRANSPLANTATION1 WW Pfaff, RJ Howard, PR Patton, VR Adams, CB Rosen, AI Reed Transplantation 65 (2), 219-223, 1998 | 160 | 1998 |
| Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects AK Bence, EB Anderson, MA Halepota, MA Doukas, PA DeSimone, ... Investigational new drugs 23, 39-49, 2005 | 152 | 2005 |
| Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization X Dong, CA Mattingly, M Tseng, M Cho, VR Adams, RJ Mumper European journal of pharmaceutics and biopharmaceutics 72 (1), 9-17, 2009 | 117 | 2009 |
| PD‐1 pathway inhibitors: immuno‐oncology agents for restoring antitumor immune responses PJ Medina, VR Adams Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (3 …, 2016 | 104 | 2016 |
| Multiple sclerosis outcomes after cancer immunotherapy CR Garcia, R Jayswal, V Adams, LB Anthony, JL Villano Clinical and Translational Oncology 21, 1336-1342, 2019 | 80 | 2019 |
| Risk stratification for bleeding complications in patients with venous thromboembolism: application of the HAS‐BLED bleeding score during the first 6 months of anticoagulant … JD Brown, AJ Goodin, GYH Lip, VR Adams Journal of the American Heart Association 7 (6), e007901, 2018 | 76 | 2018 |
| Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings RD Harvey, VR Adams, T Beardslee, P Medina Journal of Oncology Pharmacy Practice 26 (6), 1461-1474, 2020 | 74 | 2020 |
| Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort JD Brown, D Raissi, Q Han, VR Adams, JC Talbert Journal of the American Heart Association 6 (9), e006708, 2017 | 67 | 2017 |
| Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study GL Phillips, B Meisenberg, DE Reece, VR Adams, A Badros, J Brunner, ... Biology of Blood and Marrow Transplantation 10 (7), 473-483, 2004 | 67 | 2004 |
| Generation of New Landomycins with Altered Saccharide Patterns through Over‐expression of the Glycosyltransferase Gene lanGT3 in the Biosynthetic Gene Cluster of … L Zhu, A Luzhetskyy, M Luzhetska, C Mattingly, V Adams, A Bechthold, ... ChemBioChem 8 (1), 83-88, 2007 | 65 | 2007 |
| Cytotoxic activities of new jadomycin derivatives JT Zheng, U Rix, L Zhao, C Mattingly, V Adams, Q Chen, J Rohr, KQ Yang The Journal of antibiotics 58 (6), 405-408, 2005 | 64 | 2005 |
| Generation of novel landomycins M and O through targeted gene disruption A Luzhetskyy, L Zhu, M Gibson, M Fedoryshyn, C Dürr, C Hofmann, ... ChemBioChem 6 (4), 675-678, 2005 | 61 | 2005 |
| The antiproliferative and immunotoxic effects of L-canavanine and L-canaline AK Bence, DR Worthen, VR Adams, PA Crooks Anti-Cancer Drugs 13 (3), 313-320, 2002 | 61 | 2002 |
| Biotechnology Update: First MAb Approved for Treatment of Metastatic Breast Cancer TL Brenner, VR Adams Journal of the American Pharmaceutical Association (1996) 39 (2), 236-238, 1999 | 56 | 1999 |
| Targeting the PD-1 pathway in pediatric solid tumors and brain tumors LM Wagner, VR Adams OncoTargets and therapy, 2097-2106, 2017 | 55 | 2017 |
| The influence of antidiabetic medications on the development and progression of prostate cancer A Hitron, V Adams, J Talbert, D Steinke Cancer Epidemiology 36 (4), e243-e250, 2012 | 55 | 2012 |
| Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors A Hitron, D Steinke, S Sutphin, A Lawson, J Talbert, V Adams Journal of Oncology Pharmacy Practice 17 (4), 312-319, 2011 | 51 | 2011 |
| Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults AM Cook, C Martin, VR Adams, RS Morehead Antimicrobial agents and chemotherapy 55 (7), 3240-3243, 2011 | 47 | 2011 |
